INTRODUCTION
Parenteral nutrition (PN) therapy involves the intravenous administration of nutritionally adequate admixtures consisting of water, dextrose, amino acids, electrolytes, vitamins and trace elements to patients who are unable to tolerate oral or enteral feeding. 1 When all the daily nutritional requirements are exclusively supplied to the patient by PN formulations, the therapy is called Total parenteral nutrition (TPN). This therapy has become a lifeline for patients with various clinical conditions such as premature neonates, critically ill patients and patients with permanent loss of gastrointestinal function. Parenteral nutrition therapy is ideally provided to patients by a multidisciplinary team called the Nutrition Support Team (NST) which consists of a physician, pharmacist, dietician and nurse who coordinate their efforts to optimize patient care. 2, 3 Pharmacists are potentially able to contribute to the care of patients receiving PN therapy 4 and to be an integral part of the NST. 5, 6 They are educated about the physiochemical compatibilities of parenteral solutions, pharmacotherapy principles and pharmaceutical care practice. 7 Moreover, they can receive special training on nutritional support to develop specialized practice. 3 Nutrition Support Pharmacy is a speciality with a focus on optimizing nutrition support therapy outcomes. 3 However, the role of the pharmacist in PN therapy can vary among healthcare settings depending on the pharmacist's position, education and practice environment. 3 This can range from having a limited role in compounding TPN formulations to the provision of direct patient care. 3 Nutrition support pharmacists can provide variety of beneficial services related to PN therapy. Their scope of practice may include various roles such as the provision of direct patient care; consultations with other healthcare professionals, including those in entrepreneurial/industry; education of patients, caregivers, students, postgraduate trainees, colleagues, and the public; supervision of the compounding and dispensing of safe and effective TPN formulations according to standard aseptic techniques; and participation in nutrition support related research activities and quality improvement. 3 These pharmacists can collaborate with other healthcare professionals within the NST to assess patients' nutritional needs, develop and implement an individualized nutrition care plan for
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Role of the pharmacist in parenteral nutrition therapy: challenges and opportunities to implement pharmaceutical care in Kuwait the patient, and monitor patient's response to PN therapy. 3 They can also participate in the administrative management of nutrition support services at their organizations including the development documentation, implementation, and periodic review of organizational policies/protocols related to nutrition support therapy; and the development and the maintenance of an appropriate and cost-effective nutrition support formulary. 3 Several studies have demonstrated the unique perspective, knowledge, and importance of pharmacists on NSTs and their positive impact on the efficacy and safety of PN therapy. [4] [5] [6] The involvement of these pharmacists in providing direct patient care has been found to improve patients' nutritional status and clinical outcomes, to prevent and resolve PN-related complications, and to achieve significant cost savings. [8] [9] [10] The primary mission of the pharmacist is to provide pharmaceutical care which involves the direct responsible provision of medication-related care for the purpose of achieving definite outcomes that improve a patient's quality of life. 11 This can be particularly relevant to PN therapy in view of the clinical nature of this task among the pharmacists' activities. 12 However, the implementation of pharmaceutical care practice has been suboptimal in many countries due to several barriers such as time constraints, insufficient staff and deficient clinical knowledge and communication skills of personnel. [13] [14] [15] [16] Pharmaceutical care is a collaborative process in which the pharmacist works directly with other healthcare professionals and the patient to design, implement, and monitor a therapeutic plan. 11, 14 In line with this, PN therapy is ideally viewed as a multidisciplinary service in which the pharmacist collaborates with other disciplines to optimize a patient's nutrition care plan. 2, 3 It is also an area where patient-oriented pharmaceutical care services have proven of value in countries where these services are well utilized. 12, 17 Therefore, PN therapy presents an ideal opportunity for the pharmacist to participate as part of a multidisciplinary team in the delivery of safe and effective nutrition care to patients. Furthermore, they can optimize the therapeutic management of these patients by detecting and resolving medication errors and/or drug-related problems. 17 Healthcare is provided to patients in Kuwait primarily through the governmental healthcare sector at primary, secondary, and tertiary care levels. Pharmacists working in these settings have diverse educational backgrounds, with education and training from Kuwait and other countries. Hospital pharmacy TPN services were introduced into governmental hospitals in 1982. Over the years, TPN services have developed and become available at the six general hospitals, as well as in one private hospital in Kuwait. Each of these hospitals has a TPN unit located within the hospital pharmacy which provides TPN preparation service. In all governmental hospitals, TPN pharmacists utilize TPN calculation software and automated compounding devices (ACDs) to prepare PN formulations. In the only private hospital which provides TPN preparation services, PN compounding and all related calculations are performed manually by the pharmacists.
Clinical pharmacy services are limited in Kuwait. 18 Pharmaceutical care services are not provided systematically by all practicing pharmacists in the country, except some individual attempts made by motivated pharmacists. 19 While there are several studies documenting pharmacists' TPN practices in developed countries [20] [21] [22] , nothing is known about pharmacists' role in PN therapy in developing countries, including Kuwait. There is also little published research about pharmaceutical care in Kuwait 15, 16, 23, 24 , but none of these publications has investigated this area of practice. The aim of this study was to explore pharmacists' current role in PN therapy in Kuwait hospitals, their sources of TPNrelated information, opinions on NSTs, perceptions about the potential barriers to the provision of pharmaceutical care in their practice and views on how to enhance their TPN practice and role in patient care.
METHODS

Study participants
The study aimed to obtain a breadth of understanding of the pharmacists' role and experiences in PN therapy in Kuwait hospitals. Due to the exploratory nature of this study, a qualitative research method was employed to understand the experiences, views and attitudes from the perspectives of the participants. 25, 26 Therefore, a decision was made to use a purposive sample by which the study participants were deliberately selected to reveal the beliefs and experiences that would be most informative to the research questions. 25 The participants were the senior TPN pharmacists (P1-P7) at the seven hospitals (H1-H7) which provide TPN services in Kuwait. This included six governmental hospitals and one private hospital.
The interviews
Data were collected via in-depth, face-to-face semistructured interviews with the pharmacists using an interview topic guide that was developed based on a literature review ( Table 1 ). The interview topic guide was reviewed by three Professors from the Kuwait University Faculty of Pharmacy and the principal investigator (a pharmacist) to enhance its content validity. The first part of the interview aimed to collect demographic details of the pharmacists and their practice site characteristics. The remainder of the interview topic guide was designed to provide a broader description and comprehensive understanding on the pharmacists' role in the asked the participants open-ended questions to gain insights into their thoughts and to allow them raise the issues that they believed important. 25 The interviews were conducted in English and were held at the pharmacists' work place (the TPN units). Each interview lasted for approximately one hour.
Ethical approval
Participants were assured of the confidentiality and anonymity of their responses. Ethical approval for the study was obtained from the Joint Committee for the Protection of Human Subjects in Research of the Health Science Centre, Kuwait University and Kuwait Institute for Medical Specialization, Kuwait.
Data analysis
The interviews with the senior TPN pharmacists were audio-recorded and transcribed verbatim. Thematic analysis was used to analyse the interviews' transcripts. 27 The transcripts were read repeatedly and the emerging topics were identified and categorized as themes and sub-themes. Qualitative approach has been increasingly used in health services research in pharmacy for descriptive objectives, for example to look at different aspects of professional practice from the point of view of groups of practitioners. 25 The identified themes in this study were used to explore and describe pharmacists' views and experiences. To enhance the rigour of qualitative data analysis 28 , the two authors carried out an independent assessment of the transcripts to identify the themes. Then, they discussed the emerging themes following their initial review of the transcripts. Any disagreements were negotiated and differences were reconciled in the proposed themes until an agreed coding frame was established. Following that, the two authors independently coded the transcripts using the defined coding frame. They evaluated all coding, reconciled differences and agreed on the final presentation of data. Attempts to guarantee the trustworthiness of the data included the transparent process of analysis, the involvement of the two authors who read and compared ideas on the transcripts, and the search for disconfirming evidence during the analysis. Quotes that support understanding of the themes/sub-themes were identified. The quotes were defined by a code: P and a number (1-7) representing a participant from a specific hospital.
RESULTS
Study participants' demographic details and practice site characteristics
Seven pharmacists were interviewed, of whom four (57.1%) were male pharmacists. Table 2 presents pharmacists' demographic characteristics. Six of the pharmacists were graduates from institutions outside Kuwait. The basic qualification of all pharmacists was BPharm degree. Only two pharmacists had postgraduate degrees. Table 3 illustrates pharmacists' practice site characteristics and their scope of practice in relation to TPN at each hospital. The number of pharmacists working at each of the TPN units was limited. The only exception was noted in the private hospital included in this study where 8 pharmacists were involved in the manual compounding of TPN formulations. The number of pharmacy technicians involved in TPN services was minimal across the hospitals.
Results from the interviews
The analysis of the interview transcripts revealed six main themes with a number of sub-themes. The identified themes and subthemes (Table 4) are described in the following section. Role of the pharmacist in TPN compounding: All participants reported that they were mainly responsible for receiving and reviewing the TPN orders, and compounding TPN formulations in the TPN units:
"We only receive the TPN orders and compound the TPN bags. We don't see the patients." (P1)
Role of the pharmacist in the design of TPN regimen: Most participants reported that they do not have any role in the nutritional assessment of the patients and the design of TPN regimens, as these tasks were performed by the physicians. Three out of the seven pharmacists participated in the design of TPN regimens. One of the pharmacists indicated that he frequently collaborates with dieticians in patients' nutritional assessment and TPN design. On the other hand, two pharmacists reported that they design the TPN regimens jointly with the physicians who approach them at the TPN unit:
"The physician visits the TPN unit with the patient file to discuss the case with the pharmacist. The physician and pharmacist together agree on the appropriate TPN formula to serve patient's needs." (P5)
Role of the pharmacist in patient monitoring: The majority of participants stated that they had no role in monitoring patients receiving PN therapy or in following-up their progress:
"We don't have any role in monitoring the patients as this is performed by the physicians and nurses." (P6)
Overall, participants reported that they had limited contact with patients on the wards. Only one participant indicated that he visited patients on the wards to assess their nutritional needs, design the TPN regimen and monitor their response to PN therapy:
"I go to the ward with the dieticians to assess the patient's nutritional requirements and design the TPN regimen" ….. "We follow the patient during PN therapy on the ward." (P2)
Role of the pharmacist in patient/caregiver education: The TPN units at three hospitals supplied TPN formulas to a limited number of home TPN patients. The pharmacists working in these settings participated in patient/caregiver education on TPN:
"The pharmacists follow up with family members/caregivers of home TPN patients to ensure their adequate education on TPN. We also developed a printed brochure on TPN administration guidelines for the nurses taking care of home TPN patients." (P2)
Administrative roles: The TPN pharmacists performed other administrative tasks such as stock control of TPN solutions and disposables. They also coordinated the work with other hospital departments such as the Infection Control Department regarding the sterility evaluation of the TPN units and the Biomedical Services Department for equipment maintenance.
Pharmacists' perceived self-confidence and job satisfaction: The variation in pharmacists' roles in PN therapy among hospitals was reflected in differences in their self-confidence and job satisfaction. Pharmacists who reported being actively involved in direct patient care (only two participants) were more confident and satisfied about their professional roles than those who were merely involved in TPN compounding (five participants):
"The pharmacist is the expert in TPN design and formulation and is more knowledgeable regarding TPN design than the physician."…"I am satisfied about the development in TPN service in Kuwait hospitals and the increasing Poor undergraduate training on PN therapy: Participants felt that their undergraduate education and training related to TPN were inadequate to meet the responsibilities of their current jobs:
"Our background knowledge regarding TPN from our undergraduate study is limited and the type of work we are involved in is critical. We need more training." (P1)
Lack of access to continuing professional development programmes on PN therapy: Some participants complained about lack of continuing educational programmes on PN therapy for pharmacists:
"Unfortunately, we don't have any continuing medical education (CME) activities related to TPN in Kuwait." (P3)
When being asked about their sources of information and how they update their knowledge on PN therapy, participants stated that they use textbooks, scientific journals and websites, especially the American Society for Parenteral and Enteral Nutrition (ASPEN) website. Only one pharmacist reported that she once attended a scientific meeting on TPN abroad.
Pharmacist-physician collaboration
Participants reported that they interacted daily with the physicians who request PN therapy. The specialities mostly involved were the pediatricians, intensive care physicians, surgeons and gastroenterologists. Evidence of both active and poor pharmacists-physicians collaboration emerged from the interviews.
Active pharmacist-physician collaboration: Two participants described a collaborative relationship with some physicians, in which the physician trusts the pharmacist as a partner in patient care:
"The assessment of the case is performed together by the physician and pharmacist. Most physicians depend on pharmacists for the design of TPN regimens." (P3)
" (P2)
Some participants indicated that the physicians took over all the therapeutic decisions related to PN therapy, excluding the pharmacists from having any role in patient care. They mentioned that some physicians were uncooperative with pharmacists or resistant to their role on the wards: "There is one physician who doesn't request any TPN formulas through our unit. You can't force some physicians to cooperate." (P3)
"As pharmacists, we are not allowed to enter the area where the physicians work." (P4)
Views on NSTs
After providing participants with the definition of a NST, none of them reported the existence of such team at the hospitals. Participants' views on NSTs were then explored. These views are outlined in the next section.
Pharmacists' preferences regarding team approach to patient care: All participants expressed preference for the collaborative approach to patient care that can be delivered by a NST, through which the pharmacist can be actively involved in patient care: "I certainly prefer the team approach. I also hope that the pharmacists can go with the physicians to the wards to assess patients and jointly take the therapeutic decisions related to TPN." (P4) Benefits of NSTs: Participants identified several potential benefits of NSTs including enhanced communication and knowledge/opinions exchange among practitioners, time saving and improved service:
"This team will give us different opinions from different healthcare professionals resulting in better outcomes for the patient and decreased errors." (P1) "It will save the time for the pharmacists and improve the service." (P6)
Barriers to the existence of NSTs at hospitals: Participants listed a number of barriers to the development of NSTs at the hospitals. These Katoue "I think the absence of this team is due to organizational issues, e.g. lack of guidelines to develop NSTs at hospitals. In addition, there may be insufficient staff to establish NST." (P1) "The physicians believe that PN therapy is their own responsibility. They take over all the decisions related to TPN." (P4) 5 . Perceived barriers to optimizing pharmacist role in patient care and TPN services After informing the participants about the definition of pharmaceutical care 11 , they identified several barriers to implementing pharmaceutical care in their practice in relation to TPN. These barriers were categorized as general organizational barriers and pharmacist-specific barriers as described in the following section.
General organizational barriers:
Lack of a reliable source of information on TPN: Participants perceived the lack of a reliable source of information related to TPN as one of the main barriers to optimizing their practices:
"We don't have specific source of information about TPN. It depends on the pharmacistdependent search for information." (P1)
Lack of a standard operating procedure across the hospitals: Participants cited the variation in the TPN operating procedures across the hospitals as another barrier to optimal TPN service. This can influence the role of the pharmacist in maintaining safe communication between the hospitals and consequently, patient safety at transition of care between these settings: "We don't have a standard reference for our work. Each hospital has its own TPN protocol which is different from one hospital to another. This can create communication problems among the hospitals."(P4) Lack of time: Many participants complained of the overwhelming workload and lack of time which prevent them from having an active role in patient care:
"I used to go to the wards myself to check patients' medical charts, but now because of the overwhelming load that we have and lack of time, I review patients' lab results with their TPN orders at the TPN unit." (P5) The current study shows that pharmacists were mainly performing traditional tasks such as compounding and dispensing of TPN formulations. This is in line with the reported general practice of hospital pharmacists in Kuwait, which mainly involved technical roles such as filling drug orders and stock control. 18 Most pharmacists had very limited contact with patients on the wards. However, a clinical pharmacist-based TPN service has been shown to improve patients' nutritional status and clinical outcomes as compared to the conventional care provided by staff nurses. 10 Only two pharmacists reported that they visited patients on the wards (one pharmacist collaborated with the physicians and the other with the dieticians) to participate in patients assessment and the design of TPN regimens, and one of them monitored patients' response to PN therapy. Parenteral nutrition is a high-risk nutrition support modality and patients receiving this therapy need close monitoring to avoid PN-related complications. 29, 30 Pharmacists' involvement in monitoring these patients has long been proven to reduce costs and improve the patients' clinical outcomes 8, 9 and to resolve complications. 4 Pharmacists with the adequate clinical training and specialty qualifications can develop and implement useful clinical pharmacy services in specialized areas such as renal dialysis 31 and oncology. 32 In a qualitative study about the role of pharmacists in outpatient dialysis centres, Salgado et al. showed that pharmacists demonstrated positive attitudes towards implementing a number of pharmacy services including medication reconciliation, medication review, patient education, promotion of compliance and involvement in protocol development. 31 Therefore, there is an opportunity to improve the quality of care provided to patients receiving PN therapy in Kuwait hospitals by more involvement of pharmacists in the provision of clinical services to these patients. To be able to fulfill the requirements of that role, pharmacists need adequate educational preparation and clinical training on nutrition support.
The results of this study show that TPN pharmacists in Kuwait hospitals had various educational backgrounds and training levels related to PN therapy. The interviews highlighted an apparent need for educational preparation of pharmacists to undertake expanded practice roles. Participants recommended reinforcing TPN-related education and training at both undergraduate and continuing professional development levels. Pharmacists practicing in nutrition support must receive formal education and training with continuous competency assessment to take on their roles and responsibilities. 33 A professional organization such as ASPEN defines the qualifications required of nutrition support pharmacists.
3 These pharmacists should demonstrate competence in nutrition support by either the completion of an educational training program in nutrition support therapy or the certification in nutrition support by a credentialing body such as the Board of Pharmacy Specialities (USA). 3 This study identified lack of pharmacists Katoue 33 Upon completion of this program, pharmacists must demonstrate competence by being able to pass a proficiency examination. 34 Moreover, organizing continuing professional development programs on nutrition support therapy for practicing TPN pharmacists is needed to enhance their practices. Pharmacy students must be provided with adequate clinical training on the care of patients receiving PN therapy. Pharmacists prepared with adequate competencies, qualifications, and certifications on nutrition support are likely to contribute effectively to the tasks of NSTs and to patient care. This study also showed that pharmacists relied on multiple different sources of TPN-related information. A standard reliable reference for TPN-related information needs to be provided for pharmacists. The Kuwait Ministry of Health and Kuwait University Faculty of Pharmacy must collaborate to address the educational and information needs of TPN pharmacists in Kuwait.
In the present study, participants reported daily communication with physicians to clarify or adjust TPN order forms. Prescription errors in standardized TPN order forms are common reasons for pharmacists to query physicians. 35 Few participants recalled good collaboration experiences with some physicians, in which the physician trusts the pharmacist as an expert in TPN design and compounding. Physicians' lack of knowledge about TPN could have motivated them to rely on pharmacists for this service. 4 This makes this aspect of patient care ideal to initiate pharmacistphysician collaborative practice. Sanchez et al. have demonstrated that adding a pharmacist to the care team providing PN therapy permitted direct intervention in partnership with physicians to be made, and was an effective approach for preventing and resolving PN-associated complications. 12 Other participants reported that physicians assumed total responsibility over all therapeutic decisions or were resistant to pharmacists' role in patient care. Pharmaceutical care practice requires good interprofessional working relationship between pharmacists and physicians.
14 Lack of communication/coordination with physicians and lack of physicians' trust in the pharmacists' abilities have been cited as barriers to pharmaceutical care. 16, 23, 24 Physicians in Kuwait have been found to be reluctant to accept pharmacists' provision of direct patient care. 36 However, pharmacists involvement in PN therapy alongside physicians has been proven of value in improving patients' nutrition support therapy outcomes 4, 37 and in preventing and resolving PN-associated complications. 12 This study shows that the involvement of pharmacists in providing pharmaceutical care services to patient receiving PN therapy is currently limited in Kuwait and seems to depend on individual pharmacist initiative. Most of these pharmacists were relying on self-directed learning to enhance their knowledge on TPN. Interestingly, participants who had a role in providing direct patient care were more confident and satisfied about their roles than those who were only involved in TPN compounding. Pharmacists' contribution to nutritional support services has been found to enhance recognition of pharmacists as resources by physicians, and increase job satisfaction for pharmacists. 37 This also supports the findings of an earlier study among hospital pharmacists in Kuwait, in which most participants believed that pharmaceutical care practice is professionally rewarding. 16 Therefore, the involvement of pharmacists in the clinical areas of TPN would probably improve the efficacy and safety of this therapy, enhance the recognition of pharmacists by physicians as partners in patient care, and increase job satisfaction for pharmacists. This can only be achieved when the pharmacists possess the necessary competencies and formal qualifications in nutrition support. Instead of working in TPN units, pharmacists with adequate expertise in nutrition support should be encouraged to work with physicians on the wards. This would promote physicians' confidence in the pharmacists' clinical abilities and, consequently their partnership in patient care.
A team approach exemplified by NSTs was favoured by all participants, yet none of the hospitals had such teams. Dedicated NSTs, which routinely included pharmacists, have been employed to coordinate the delivery of PN therapy in many countries. 2, 20, 21, 38 Team approach to the care of patients receiving PN therapy ensures the clinical appropriateness of PN therapy 2, 5, 21 , maximizes the efficiency of using the available resources 39 and minimizes PN-associated complications. 5, 21, 30, 40 There is a growing evidence showing that the involvement of NSTs in the management of nutrition support services helps avoid the inappropriate/non-justified PN therapy use and PN-associated metabolic and aseptic complications which translates into substantial cost savings. 5, 41, 42 Pharmacists identified several potential benefits for NSTs, including enhanced communication and knowledge/opinions exchange amongst practitioners, time saving and improved service. In view of the established and perceived benefits of NSTs, healthcare professionals involved in PN therapy at hospitals of Kuwait are advised to coordinate their efforts within functional, wellmanaged NSTs to improve quality of care and cost expenditure.
Study participants' perceived barriers to the existence of NSTs were organizational / administrative barriers such as lack of guidelines for the development of NSTs, shortage of staff and physicians' assuming total responsibility for clinical decision-making. Physicians' attitudes including skepticism, rivalry, and ignorance have been among the problems that faced NSTs in the period of their growth in the USA. 38 Lack of interest from the medical staff could have limited the role of NSTs in patient care in other countries. 21 Physicians need to be educated about the benefits of NSTs in optimizing the clinical and economical management of nutrition support services. The study revealed lack of trained nutrition support staff and lack of coordination in delivering TPN care. Efforts are needed to prepare healthcare professionals with nutritional expertise who can work in a collaborative manner within proactive and well-managed NSTs. One way to enhance collaborative practice among healthcare professionals could be through providing interprofessional educational (IPE) opportunities for undergraduate healthcare students. This would allow students from each healthcare profession appreciate the value of the contributions made by other disciplines in patient care and, consequently promote the development of collaborative working relationships among future healthcare practitioners. The World Health Organization recognizes IPE as a necessary educational strategy to prepare collaborative healthcare practitioners who have learned how to work in an interprofessional team and are competent to do so. 43 There is also sufficient evidence to indicate that effective IPE enables effective collaborative practice 43 and can help improving the pharmacist-physician working relationship. 7, 44 Moreover, establishing national standards of TPN practices which include explicit guidelines on the development of NSTs is urgently needed.
In this study, participants identified several barriers to pharmaceutical care practice and they provided suggestions to overcome these barriers to enhance their role in patient care. Lack of a standard reference for TPN-related information and lack of standardization of TPN practices across hospitals were perceived as main organizational barriers to the pharmacist provision of optimal TPN services. The participants called for the development of a standard reference for safe TPN practices. A standardized process for TPN practices would improve patient safety and clinical appropriateness, and maximize resource efficiency. 45 This can overcome any miscommunication problems and ensure a seamless nutritional management for patients upon their transition between healthcare settings. Pharmacists felt that they had minimal role in the management of patients' care plans and the selection of TPN formulary. Pharmacists' participation in active NSTs can overcome these barriers, as this would allow them provide direct patient care and have a role in the development of TPN guidelines/standards and the selection of TPN formulary. 21 To undertake these roles, pharmacists would require adequate education and training on nutrition support. There was an overwhelming consensus among participants on the need to foster pharmacists' education on PN therapy to enhance their role in patient care. Other reported organizational barriers included shortage of staff and time constraints, which concur with the reported barriers to pharmaceutical care in previous studies conducted in Kuwait. 15, 16, 23, 24 The number of pharmacists working at each TPN unit was minimal which can explain the limited role of the pharmacists in performing TPN compounding tasks and their lack of time to provide direct patient care. In addition, only four hospitals employed one or two pharmacy technicians in the TPN units. Many participants recommended for the provision of more pharmacy staff and they stressed on the need to provide qualified pharmacy technicians to assist pharmacists in TPN compounding. Lack of pharmacist time can be partly overcome by better delineation between the roles of the pharmacist and the pharmacy technician. Allocating technical tasks such as TPN compounding and dispensing duties to technicians can permit role redesign and free-up the pharmacist's time to provide patient-centered care. Participants demonstrated positive attitudes towards team approach to patient care and they recommended for the development of NSTs to supervise the delivery of PN therapy. Using practitioners with nutrition support therapy expertise will contribute to the execution of safe PN system. 3, 45 Some participants suggested enhancing communication among TPN pharmacists and conducting research activities locally to address the issues they face in their practice. Health authorities need to consider these suggestions to enhance the quality of TPN services at Kuwait hospitals.
This study explored pharmacists' role in PN therapy and the barriers that hinder the implementation of pharmaceutical care services in this specialized area of practice. Further studies are needed to explore the opinions of other healthcare professionals including physicians, dieticians, and nurses in team approach to PN therapy and the barriers towards having functional NSTs. Identifying these barriers will help health authorities plan appropriate strategies to enhance the delivery of collaborative care to patients receiving PN therapy. Moreover, conducting future studies to evaluate the impact of pharmaceutical care services on the clinical and economical outcomes of PN therapy are also warranted once these services are provided systemically by TPN pharmacists in Kuwait hospitals.
Limitations
Some of the limitations that influence qualitative research in general apply to this study. A possible limitation is the participants' self-reporting of practices and experiences. It is possible that pharmacists offered sociably desirable responses. However, this is less likely as they were assured about the confidentiality of their responses. Furthermore, the sample size included in this study was small and involved only seven participants. In qualitative research, the sample size is determined by the research questions and data saturation. 25 These were fulfilled by the comprehensive range of responses that were obtained from the seven participants who represented all the hospitals which provide TPN preparation services in Kuwait. Another limitation is that the findings of this study may not be generalizable to other countries. However, the transferability of these findings to other contexts might be possible if they can be considered appropriate/applicable to these settings.
CONCLUSIONS
Pharmacists practicing in TPN in Kuwait hospitals are mainly performing technical tasks such as TPN compounding. There are several barriers to the provision of optimal pharmaceutical care services in Katoue MG , Al-Taweel D. Role of the pharmacist in parenteral nutrition therapy: challenges and opportunities to implement pharmaceutical care in Kuwait. Pharmacy Practice 2016 Jan-Mar;14(2):680. doi: 10.18549/PharmPract.2016.02.680 their practices, including organizational and professional barriers. Health authorities and educational institutions must collaborate to overcome these barriers and assist the pharmacists to undertake expanded practice roles. Pharmacists must be provided with appropriate educational preparation to practise as nutrition support pharmacists with patient-centred roles. Healthcare professionals, including pharmacists with adequate clinical training and advanced certifications in nutrition support who practise within active NSTs are pivotal to the delivery of safe and efficacious PN therapy.
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